Clinical Trials Browser

Rosiglitazone × Dermatologic × Clear all

NCT04114136 2026-04-24

Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies

Phase 2 Recruiting

DermatologicGastrointestinalHead & Neck

Adenocarcinoma Of Esophagus, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Hepatocellular, Melanoma

NCT00178841 2016-02-17

Combination Drug Study of Bexarotene and Rosiglitazone to Treat CTCL

Phase 2 Completed

4 enrolled 5 charts

DermatologicLymphoid

Mycosis Fungoides, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous